Skip to main content

Want a detailed portfolio tracker?

Alaunos Therapeutics (TCRT) P/E (2010 - 2026)

Alaunos Therapeutics (TCRT) P/E from Jun 30, 2010 to Jun 3, 2026. The TTM Alaunos Therapeutics (TCRT) P/E is -1.43. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alaunos Therapeutics (TCRT)

YearP/EChange
2026-1.43-8.12%
2025-1.55+138.36%
2024-0.65+39.65%
2023-0.47-86.58%
2022-3.48+16.38%
2021-2.99-55.78%
2020-6.76-4.40%
2019-7.07+37.07%
2018-5.16-52.47%
2017-10.85+151.61%
2016-4.31-51.80%
2015-8.94-45.19%
2014-16.32+150.04%
2013-6.53+59.86%
2012-4.08+13.34%
2011-3.60-97.38%
2010-137.72N/A

Comparison Alaunos Therapeutics (TCRT) P/E with competitors

Alaunos Therapeutics (TCRT) P/E is -1.43.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.10-107.16%
ENLVEnlivex Therapeutics Ltd0.15-110.52%
FGENFibroGen Inc0.24-116.82%
TRAWTraws Pharma Inc0.47-133.12%
FBIOFortress Biotech Inc0.71-149.46%
CHRSCoherus Biosciences Inc0.98-168.52%
ORMPOramed Pharmaceuticals Inc1.47-203.22%
AGENAgenus Inc2.05-243.50%
VIVSVivoSim Labs Inc2.54-277.64%
INVAInnoviva Inc3.19-323.36%
CRMDCorMedix Inc3.65-355.39%
ABEOAbeona Therapeutics Inc4.20-394.57%
VXRTVaxart Inc4.26-398.54%
CVACCureVac N.V.4.45-411.43%
SRPTSarepta Therapeutics Inc4.62-423.94%
GLPGGalapagos NV4.86-440.37%
RIGLRigel Pharmaceuticals4.92-444.63%
ZVRAZevra Therapeutics Inc4.97-448.44%
ABUSArbutus Biopharma Corp5.69-498.86%
CGENCompugen Ltd7.38-617.27%
AUPHAurinia Pharmaceuticals Inc9.25-748.09%
ACADAcadia Pharmaceuticals Inc9.59-771.68%
OMEROmeros Corporation9.88-792.37%
PLXProtalix BioTherapeutics Inc9.91-794.17%
SPROSpero Therapeutics Inc10.73-852.01%
ADMAAdma Biologics Inc11.33-893.75%
SVASinovac Biotech Ltd11.44-901.14%
TBPHTheravance Biopharma Inc11.78-925.00%
HRMYHarmony Biosciences Holdings Inc12.18-953.28%
TGTXTG Therapeutics Inc13.18-1023.27%
INCYIncyte Corp13.38-1037.46%
SABSSAB Biotherapeutics Inc14.06-1084.80%
XOMAXOMA Corp14.95-1146.97%
REGNRegeneron Pharmaceuticals Inc14.98-1149.42%
PBYIPuma Biotechnology Inc15.05-1154.34%
EXELExelixis Inc15.79-1206.49%
NAGENiagen Bioscience Inc16.35-1245.73%
CPRXCatalyst Pharmaceuticals Inc17.34-1315.07%
MDXGMimedx Group Inc17.38-1317.21%
ARGXArgen X SE23.07-1716.25%
HALOHalozyme Therapeutics Inc23.20-1725.29%
XOMAOXOMA Corp25.34-1875.50%
VRTXVertex Pharmaceuticals Inc25.66-1897.29%
XOMAPXOMA Corp25.67-1898.29%
CTMXCytomX Therapeutics Inc25.70-1900.24%
ASNDAscendis Pharma A/S26.35-1946.21%
RPRXRoyalty Pharma plc - Class A27.50-2026.16%
SLNOSoleno Therapeutics Inc29.02-2132.64%
LGNDLigand Pharmaceuticals Inc - Class B30.19-2214.68%
BMRNBiomarin Pharmaceutical Inc37.51-2727.53%
APLSApellis Pharmaceuticals Inc39.02-2833.59%
KRYSKrystal Biotech Inc39.70-2880.97%
GMABGenmab40.20-2916.42%
ONCBeiGene Ltd67.03-4795.51%
TECHBio-Techne Corp68.59-4905.36%
VCELVericel Corp80.63-5748.40%
PHARPharming Group N.V.87.74-6246.55%
ALNYAlnylam Pharmaceuticals Inc124.93-8852.11%
TLXTelix Pharmaceuticals Ltd139.89-9899.90%
CORTCorcept Therapeutics Inc158.39-11195.81%